10-122461729-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002775.5(HTRA1):​c.77G>A​(p.Arg26Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00328 in 1,181,636 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R26W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 53 hom. )

Consequence

HTRA1
NM_002775.5 missense

Scores

1
1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.228

Publications

2 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018782914).
BP6
Variant 10-122461729-G-A is Benign according to our data. Variant chr10-122461729-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 299045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0504 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.77G>A p.Arg26Gln missense_variant Exon 1 of 9 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.77G>A p.Arg26Gln missense_variant Exon 1 of 9 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.154+3020G>A intron_variant Intron 1 of 8 ENSP00000498033.1 A0A3B3IU24

Frequencies

GnomAD3 genomes
AF:
0.0130
AC:
1924
AN:
147674
Hom.:
33
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0428
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00652
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00767
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000271
Gnomad OTH
AF:
0.00837
GnomAD2 exomes
AF:
0.00407
AC:
185
AN:
45490
AF XY:
0.00479
show subpopulations
Gnomad AFR exome
AF:
0.0530
Gnomad AMR exome
AF:
0.00356
Gnomad ASJ exome
AF:
0.000238
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000503
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00189
AC:
1950
AN:
1033854
Hom.:
53
Cov.:
30
AF XY:
0.00202
AC XY:
1019
AN XY:
503432
show subpopulations
African (AFR)
AF:
0.0531
AC:
1038
AN:
19536
American (AMR)
AF:
0.00362
AC:
43
AN:
11882
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12500
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13340
South Asian (SAS)
AF:
0.0105
AC:
456
AN:
43578
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
14598
Middle Eastern (MID)
AF:
0.00402
AC:
10
AN:
2488
European-Non Finnish (NFE)
AF:
0.000247
AC:
217
AN:
878834
Other (OTH)
AF:
0.00501
AC:
186
AN:
37098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1929
AN:
147782
Hom.:
32
Cov.:
32
AF XY:
0.0127
AC XY:
913
AN XY:
72018
show subpopulations
African (AFR)
AF:
0.0428
AC:
1760
AN:
41092
American (AMR)
AF:
0.00645
AC:
96
AN:
14888
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3402
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5106
South Asian (SAS)
AF:
0.00726
AC:
35
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8916
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.000271
AC:
18
AN:
66302
Other (OTH)
AF:
0.00828
AC:
17
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
89
179
268
358
447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
ExAC
AF:
0.00461
AC:
90

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 12, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Macular degeneration Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.23
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
0.050
N
REVEL
Benign
0.18
Sift
Benign
0.29
T
Sift4G
Benign
0.32
T
Polyphen
0.25
B
Vest4
0.073
MVP
0.86
MPC
0.59
ClinPred
0.0072
T
GERP RS
2.9
PromoterAI
0.068
Neutral
Varity_R
0.093
gMVP
0.38
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190036021; hg19: chr10-124221245; API